CDC Solutions Continues Global Expansion and Steady Growth with New Customers and Increased Presence in Key Market Sectors.

Business Editors/Health/Medical Writers

PHILADELPHIA & CHIPPENHAM, UK--(BUSINESS WIRE)--July 25, 2003

CDC's successful software division is now complimented by client-focused services to ensure growth now and in the future

CDC Solutions Ltd (CDC) (www.cdcsolutions.com), the acknowledged market leader in compliance-ready, document-based solutions in the life sciences industries, today announced continued growth for quarter ended June 30, 2003 with a 20 percent increase in revenues over the same period last year and a 19 percent sequential increase over quarter ended March 31, 2003. Software license revenues represent 64 percent and service revenues represent 36 percent of the total revenues for Q2. As CDC's customer base continues to grow, so too does its expert sales, regulatory and technical teams in order to accommodate the demand for software and services in key locations.

In addition to existing customers continuing to invest, CDC secured eight life sciences companies as new customers in Q2. Among these notable new wins are global corporate contracts from Bayer AG and Daiichi Pharmaceutical Co., Ltd. These contracts are another example of how the market is driving CDC's leading position as the vendor of choice for electronic regulatory submissions.

"As a company we have spent a great deal of effort tailoring our services and solutions to meet the demands of international companies that need to compile and publish mission-critical regulatory documentation," said Philip Padfield, President and CEO at CDC Solutions. "I am extremely pleased at our continued growth and with the healthy split of our software license and service revenue. We had some strategic wins in Q2, which we attribute to mature product, outstanding services and our dedication to our client base," added Philip.

In the first quarter of 2003, CDC's Global Customer Service (GCS) division announced the launch of EZsubs(R) Express and the opening of the new state-of-the-art publishing centers in the US and UK. EZsubs Express combines software and services to provide a complete and customized package for clients who want to outsource entire submissions or who wish to bring all of the tools, including staff and services, in-house to complete the project. In Q2 CDC's GCS group successfully completed a full outsource submission to the FDA. To help support this area of growth, CDC has expanded the services division by adding regulatory GCS staff to the West coast, USA office.

Philip continued, "We are so pleased to have successfully completed our first submission within the EZsubs Express offering. Our staff is made up of experienced publishers and regulatory experts originating from major life sciences companies. It was gratifying to see how efficiently our strengths came together in support of client needs. We look forward to completing the new business coming our way in Q3 and Q4."

At the end of June, CDC released the newest version of its flagship product, EZsubs 5.4, a premier choice for international companies wanting to submit to the global regulatory agencies around the world. The redesigned foundation of EZsubs is now Unicode based providing support for multi-byte character sets used in languages such as Japanese, Chinese and Korean. CDC Solutions expansion into Japan in mid-2002 was prompted by Japanese life sciences companies fast becoming global players targeting the North American and European markets. EZsubs provides Japanese customers with the ability to compile and publish submissions in both Japanese and English and also gives Japanese clients the ability to create an eCTD entirely in Japanese. CDC has opened a Tokyo office and has hired Japanese nationals as part of the sales and pre-sales teams.

About CDC Solutions Ltd.

Founded in 1994, CDC Solutions (CDC) is the acknowledged market leader in compliance-ready, document-based solutions to the life sciences industries. Our offerings help clients achieve compliance and accuracy as they deliver mission-critical regulatory reports and submissions.

CDC's flagship offerings, including the EZsubs(R) publishing suites and PDFaqua, which enable small and large pharmaceutical, biotechnology and medical device companies gain process efficiencies and decrease time to market while meeting the strict standards of regulatory authorities around the world. For more information, call [phone] (United Kingdom) or +1 610.834.9021 (CDC Solutions Inc., North America), or visit the CDC Solutions website at www.cdcsolutions.com.

CDC Solutions, EZsubs, PDFfusion, PDFrender, PDFaqua, PDFcontrol, Xtensia, Xssembler, and Xport are trademarks or registered trademarks, service marks or registered service marks of CDC Solutions Ltd. All other product and company names mentioned herein may be trademarks of their respective holders.